Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Articles
Original Research
,
Clinical
Migration of Hospital Total Hip and Knee Arthroplasty Procedures to an Ambulatory Surgery Center Setting and Postsurgical Opioid Use: A Private Practice Experience
James Van Horne, MD; Alaine Van Horne, BS; Nick Liao, MS; Victoria Romo-LeTourneau, PharmD
Read More
Original Research
,
Business
Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019
Mohammed M. Alsultan, PharmD, PhD; Jeff Jianfei Guo, BPharm, PhD
Read More
FDA Approvals
Keytruda Now Approved for the Adjuvant Treatment of Stage IIB/IIC Melanoma
Read More
FDA Approvals
Orencia First Drug FDA Approved for the Prevention of Acute Graft-versus-Host Disease
Read More
FDA Approvals
Kimmtrak, a Bispecific CD3 T-Cell Engager, First FDA-Approved Drug for Unresectable or Metastatic Uveal Melanoma
Read More
FDA Approvals
FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor
Read More
FDA Approvals
Oral Scemblix FDA Approved for Patients with Ph-Positive Chronic Myeloid Leukemia
Read More
FDA Approvals
Tecartus FDA Approved for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Read More
FDA Approvals
Verzenio with Endocrine Therapy FDA Approved for Adjuvant Treatment of Early Breast Cancer
Read More
Editorial
A Pandemic Literary Genre
David B. Nash, MD, MBA
Read More
10
11
12
13
14
15
16
Page 13 of 246
Results 121 - 130 of 2457